Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study have?
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study has 160 citations in the OpenAlex counts ScholarIQ stores.
When was Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study published?
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study has 2020 year in the ScholarIQ index.
What is the open-access status of Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study?
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study has bronze oa status in the ScholarIQ index.
What is the DOI of Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study?
The DOI for Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study is on the source record.
What is the PMID of Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study?
The PMID for Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study is on the source record.
What is the OpenAlex record for Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study?
The OpenAlex for Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study is on the source record.